Ketogenic diet protects MPTP‐induced mouse model of Parkinson's disease via altering gut microbiota and metabolites

Abstract The ketogenic diet (KD) is a low‐carbohydrate, high‐fat regime that is protective against neurodegenerative diseases. However, the impact of KD on Parkinson's disease (PD) and its mechanisms remains unclear. 1‐Methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced mouse model of PD...

Full description

Bibliographic Details
Main Authors: Ziying Jiang, Xinyu Wang, Haoqiang Zhang, Jian Yin, Peiqing Zhao, Qingqing Yin, Zhenfu Wang
Format: Article
Language:English
Published: Wiley 2023-06-01
Series:MedComm
Subjects:
Online Access:https://doi.org/10.1002/mco2.268
_version_ 1797802552940560384
author Ziying Jiang
Xinyu Wang
Haoqiang Zhang
Jian Yin
Peiqing Zhao
Qingqing Yin
Zhenfu Wang
author_facet Ziying Jiang
Xinyu Wang
Haoqiang Zhang
Jian Yin
Peiqing Zhao
Qingqing Yin
Zhenfu Wang
author_sort Ziying Jiang
collection DOAJ
description Abstract The ketogenic diet (KD) is a low‐carbohydrate, high‐fat regime that is protective against neurodegenerative diseases. However, the impact of KD on Parkinson's disease (PD) and its mechanisms remains unclear. 1‐Methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced mouse model of PD was fed with KD for 8 weeks. Motor function and dopaminergic neurons were evaluated. Inflammation in the brain, plasma, and colon tissue were also measured. Fecal samples were assessed by 16S rDNA gene sequencing and untargeted metabolomics. We found that KD protected motor dysfunction, dopaminergic neuron loss, and inflammation in an MPTP mouse model of PD. 16S rDNA sequencing revealed that MPTP administration significantly increased Citrobacter, Desulfovibrio, and Ruminococcus, and decreased Dubosiella, whereas KD treatment reversed the dysbiosis. Meanwhile, KD regulated the MPTP‐induced histamine, N‐acetylputrescine, d‐aspartic acid, and other metabolites. Fecal microbiota transplantation using feces from the KD‐treated mice attenuated the motor function impairment and dopaminergic neuron loss in antibiotic‐pretreated PD mice. Our current study demonstrates that KD played a neuroprotective role in the MPTP mouse model of PD through the diet–gut microbiota–brain axis, which may involve inflammation in the brain and colon. However, future research is warranted to explore the explicit anti‐inflammatory mechanisms of the gut–brain axis in PD models fed with KD.
first_indexed 2024-03-13T05:07:24Z
format Article
id doaj.art-ed9405fc4fbe4c57a71ebf8ecfc58b4c
institution Directory Open Access Journal
issn 2688-2663
language English
last_indexed 2024-03-13T05:07:24Z
publishDate 2023-06-01
publisher Wiley
record_format Article
series MedComm
spelling doaj.art-ed9405fc4fbe4c57a71ebf8ecfc58b4c2023-06-16T09:40:37ZengWileyMedComm2688-26632023-06-0143n/an/a10.1002/mco2.268Ketogenic diet protects MPTP‐induced mouse model of Parkinson's disease via altering gut microbiota and metabolitesZiying Jiang0Xinyu Wang1Haoqiang Zhang2Jian Yin3Peiqing Zhao4Qingqing Yin5Zhenfu Wang6Department of Geriatric Neurology The Second Medical Center & National Clinical Research Center for Geriatric Disease Chinese PLA General Hospital Beijing ChinaDepartment of Geriatric Neurology Shandong Provincial Hospital Affiliated to Shandong First Medical University Jinan Shandong ChinaDepartment of Endocrinology The First Affiliated Hospital of USTC Division of Life Sciences and Medicine University of Science and Technology of China Hefei Anhui ChinaDepartment of Bio‐Medical Diagnostics Suzhou Institute of Biomedical Engineering and Technology Chinese Academy of Sciences Suzhou Jiangsu ChinaDepartment of Translational Medical Center Zibo Central Hospital Affiliated to Binzhou Medical University Zibo Shandong ChinaDepartment of Geriatric Neurology Shandong Provincial Hospital Affiliated to Shandong First Medical University Jinan Shandong ChinaDepartment of Geriatric Neurology The Second Medical Center & National Clinical Research Center for Geriatric Disease Chinese PLA General Hospital Beijing ChinaAbstract The ketogenic diet (KD) is a low‐carbohydrate, high‐fat regime that is protective against neurodegenerative diseases. However, the impact of KD on Parkinson's disease (PD) and its mechanisms remains unclear. 1‐Methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced mouse model of PD was fed with KD for 8 weeks. Motor function and dopaminergic neurons were evaluated. Inflammation in the brain, plasma, and colon tissue were also measured. Fecal samples were assessed by 16S rDNA gene sequencing and untargeted metabolomics. We found that KD protected motor dysfunction, dopaminergic neuron loss, and inflammation in an MPTP mouse model of PD. 16S rDNA sequencing revealed that MPTP administration significantly increased Citrobacter, Desulfovibrio, and Ruminococcus, and decreased Dubosiella, whereas KD treatment reversed the dysbiosis. Meanwhile, KD regulated the MPTP‐induced histamine, N‐acetylputrescine, d‐aspartic acid, and other metabolites. Fecal microbiota transplantation using feces from the KD‐treated mice attenuated the motor function impairment and dopaminergic neuron loss in antibiotic‐pretreated PD mice. Our current study demonstrates that KD played a neuroprotective role in the MPTP mouse model of PD through the diet–gut microbiota–brain axis, which may involve inflammation in the brain and colon. However, future research is warranted to explore the explicit anti‐inflammatory mechanisms of the gut–brain axis in PD models fed with KD.https://doi.org/10.1002/mco2.268gut microbiotainflammationketogenic dietmetabolitesParkinson's disease
spellingShingle Ziying Jiang
Xinyu Wang
Haoqiang Zhang
Jian Yin
Peiqing Zhao
Qingqing Yin
Zhenfu Wang
Ketogenic diet protects MPTP‐induced mouse model of Parkinson's disease via altering gut microbiota and metabolites
MedComm
gut microbiota
inflammation
ketogenic diet
metabolites
Parkinson's disease
title Ketogenic diet protects MPTP‐induced mouse model of Parkinson's disease via altering gut microbiota and metabolites
title_full Ketogenic diet protects MPTP‐induced mouse model of Parkinson's disease via altering gut microbiota and metabolites
title_fullStr Ketogenic diet protects MPTP‐induced mouse model of Parkinson's disease via altering gut microbiota and metabolites
title_full_unstemmed Ketogenic diet protects MPTP‐induced mouse model of Parkinson's disease via altering gut microbiota and metabolites
title_short Ketogenic diet protects MPTP‐induced mouse model of Parkinson's disease via altering gut microbiota and metabolites
title_sort ketogenic diet protects mptp induced mouse model of parkinson s disease via altering gut microbiota and metabolites
topic gut microbiota
inflammation
ketogenic diet
metabolites
Parkinson's disease
url https://doi.org/10.1002/mco2.268
work_keys_str_mv AT ziyingjiang ketogenicdietprotectsmptpinducedmousemodelofparkinsonsdiseaseviaalteringgutmicrobiotaandmetabolites
AT xinyuwang ketogenicdietprotectsmptpinducedmousemodelofparkinsonsdiseaseviaalteringgutmicrobiotaandmetabolites
AT haoqiangzhang ketogenicdietprotectsmptpinducedmousemodelofparkinsonsdiseaseviaalteringgutmicrobiotaandmetabolites
AT jianyin ketogenicdietprotectsmptpinducedmousemodelofparkinsonsdiseaseviaalteringgutmicrobiotaandmetabolites
AT peiqingzhao ketogenicdietprotectsmptpinducedmousemodelofparkinsonsdiseaseviaalteringgutmicrobiotaandmetabolites
AT qingqingyin ketogenicdietprotectsmptpinducedmousemodelofparkinsonsdiseaseviaalteringgutmicrobiotaandmetabolites
AT zhenfuwang ketogenicdietprotectsmptpinducedmousemodelofparkinsonsdiseaseviaalteringgutmicrobiotaandmetabolites